Impact of tumour growth rate during preceding treatment on tumour response to regorafenib or trifluridine/tipiracil in refractory metastatic colorectal cancer

BACKGROUND: Although regorafenib (REG) and trifluridine/tipiracil (FTD/TPI) have been recognised as standard treatments in metastatic colorectal cancer (mCRC), the best option remains unclear. Pretreatment tumour growth rate (TGR) is associated with radiotherapeutic efficacy in laryngeal cancer. How...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:ESMO Open
Hlavní autoři: Masuishi, Toshiki, Taniguchi, Hiroya, Kawakami, Takeshi, Kawamoto, Yasuyuki, Kadowaki, Shigenori, Onozawa, Yusuke, Muranaka, Tetsuhito, Tajika, Masahiro, Yasui, Hirofumi, Nakatsumi, Hiroshi, Yuki, Satoshi, Muro, Kei, Omae, Katsuhiro, Komatsu, Yoshito, Yamazaki, Kentaro
Médium: Artigo
Jazyk:Inglês
Vydáno: BMJ Publishing Group 2019
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7001098/
https://ncbi.nlm.nih.gov/pubmed/32392174
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/esmoopen-2019-000584
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky